AB-007 (Nanjing Aorui Pharmaceutical)

N/A

Report date: 2023/03/03 14:36:50
NME

Base Information

Drug NameAB-007 (Nanjing Aorui Pharmaceutical)
Drug Alias NameAB-007 (Nanjing Aorui Pharmaceutical)AB-007
ClassificationOther
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Aorui Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Aorui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A